China boosts cancer R&D with 2nd US Mobetron
This article was originally published in Clinica
Executive Summary
China is to boost its research into intraoperative electron-beam radiation therapy (IOERT) with the purchase of its second Mobetron (mobile electron beam radiation device). The machine, which allows large doses of radiation to be applied to a cancer tumour during surgery, will be installed at the People's Liberation Army (PLA) General Hospital, in Beijing.